Wednesday, September 07, 2022
NeoLight is proud to announce that its Skylife Neonatal Phototherapy System has been granted an Innovative Technology contract by Vizient, Inc., the leading member-driven healthcare performance improvement company. This prestigious contract recognizes the unique qualities of the Skylife system that can enhance clinical care, patient safety, and improve business operations within healthcare organizations.
The Skylife Neonatal Phototherapy System sets new standards with its Best-in-Class Spectral Power, surpassing AAP Guidelines. It offers numerous benefits, including reducing bedside equipment, decreasing nurse workload, and enabling intermittent phototherapy to promote successful breastfeeding, Kangaroo Care, and increased skin-to-skin time with families. The Skylife 3D Light Array™ ensures effective and uniform light coverage over 40% of the neonate's body surface, and clinicians can choose from three levels of irradiance for optimal care control.
Arik Anderson, CEO of NeoLight, expressed excitement about receiving the Innovative Technology contract, emphasizing the significance of best-in-class technology in the Skylife system. This contract expands their accessibility within Vizient's extensive network, allowing them to collaborate with member hospitals nationwide in their efforts to reduce jaundice-related complications, lower bilirubin levels efficiently, and significantly reduce hospital costs.
Kelly Flaharty, Senior Director of Contract Process for Vizient, congratulated NeoLight on being awarded the contract, highlighting the system's efficiencies and potential to make a meaningful difference in healthcare.
Vizient represents a diverse membership base, including academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers, with an annual purchasing volume exceeding $130 billion. Through its Innovative Technology Program, Vizient evaluates products in collaboration with member-led councils and task forces to identify real innovation in healthcare. Products deemed worthy of the Innovative Technology designation may be awarded a contract outside of the competitive bid cycle.
